EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis

Abstract Background Ovarian cancer stem cells (OCSC), endowed with tumor-initiating and self-renewal capacity, would account not only for the tumor growth, the peritoneal metastasis, and the relapse, but also for the acquisition of chemotherapy resistance. Nevertheless, figuring out their phenotypic...

Full description

Bibliographic Details
Main Authors: Kun Wang, Yiyang Wang, Yuanjian Wang, Shujie Liu, Chunyan Wang, Shuo Zhang, Tianli Zhang, Xingsheng Yang
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-021-02256-2
_version_ 1828967308682330112
author Kun Wang
Yiyang Wang
Yuanjian Wang
Shujie Liu
Chunyan Wang
Shuo Zhang
Tianli Zhang
Xingsheng Yang
author_facet Kun Wang
Yiyang Wang
Yuanjian Wang
Shujie Liu
Chunyan Wang
Shuo Zhang
Tianli Zhang
Xingsheng Yang
author_sort Kun Wang
collection DOAJ
description Abstract Background Ovarian cancer stem cells (OCSC), endowed with tumor-initiating and self-renewal capacity, would account not only for the tumor growth, the peritoneal metastasis, and the relapse, but also for the acquisition of chemotherapy resistance. Nevertheless, figuring out their phenotypical and functional traits has proven quite challenging, mainly because of the heterogeneity of ovarian cancer. A deeper understanding of OCSC mechanisms will shed light on the development of the disease. Therefore, we aim to explore it for the design of innovative treatment regimens which aim at the eradication of ovarian cancer through the elimination of the CSC component. Methods In this study, immunohistochemistry assay and western blot assay were used to detect protein expression in the primary tumor and peritoneal multi-cellular aggregates/spheroids (MCAs/MCSs). OCSCs induced from cell line SKOV3 and HO-8910 were enriched in a serum-free medium (SFM). The effect of EIF5A2 on CSC-like properties was detected by sphere-forming assays, re-differentiation assays, quantitative real-time polymerase chain reaction, western blotting, flow cytometry, cell viability assays, immunofluorescence staining, and in vivo xenograft experiments. RNA-sequencing (RNA-seq) was used to reveal the mechanism by which EIF5A2 positively modulates the stem-like properties of ovarian cancer cells. Results Expression of EIF5A2 was significantly higher in peritoneal MCAs/MCSs compared to matched primary tumors, and EIF5A2 was also unregulated in ovarian cancer cell line-derived spheroids. Knockdown of EIF5A2 reduced the expression of the stem-related markers (ALDH1A1 and OCT-4), inhibited self-renewal ability, improved the sensitivity to chemotherapeutic drugs, and inhibited tumorigenesis in vivo. Mechanistic studies revealed that EIF5A2 knockdown reduced the expression of KLF4, which could partially rescue stem-like properties abolished by EIF5A2 knockdown or strengthened by EIF5A2 overexpression, through the transcription factor E2F1, which directly bind to KLF4 promoter. Conclusion Our results imply that EIF5A2 positively regulates stemness in ovarian cancer cells via E2F1/KLF4 pathway and may serve as a potential target in CSCs-targeted therapy for ovarian cancer.
first_indexed 2024-12-14T11:47:34Z
format Article
id doaj.art-015a3eb1f1e34b62aa88e9fd6ad0b2f1
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-14T11:47:34Z
publishDate 2021-03-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-015a3eb1f1e34b62aa88e9fd6ad0b2f12022-12-21T23:02:29ZengBMCStem Cell Research & Therapy1757-65122021-03-0112111610.1186/s13287-021-02256-2EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axisKun Wang0Yiyang Wang1Yuanjian Wang2Shujie Liu3Chunyan Wang4Shuo Zhang5Tianli Zhang6Xingsheng Yang7Department of Obstetrics and Gynecology, Qilu Hospital of Shandong UniversityAffiliated Reproductive Hospital of Shandong UniversityWest China School of Medicine, Sichuan UniversityDepartment of Obstetrics and Gynecology, Qilu Hospital of Shandong UniversityDepartment of Obstetrics and Gynecology, Qilu Hospital of Shandong UniversityDepartment of Obstetrics and Gynecology, Qilu Hospital of Shandong UniversityDepartment of Obstetrics and Gynecology, Qilu Hospital of Shandong UniversityDepartment of Obstetrics and Gynecology, Qilu Hospital of Shandong UniversityAbstract Background Ovarian cancer stem cells (OCSC), endowed with tumor-initiating and self-renewal capacity, would account not only for the tumor growth, the peritoneal metastasis, and the relapse, but also for the acquisition of chemotherapy resistance. Nevertheless, figuring out their phenotypical and functional traits has proven quite challenging, mainly because of the heterogeneity of ovarian cancer. A deeper understanding of OCSC mechanisms will shed light on the development of the disease. Therefore, we aim to explore it for the design of innovative treatment regimens which aim at the eradication of ovarian cancer through the elimination of the CSC component. Methods In this study, immunohistochemistry assay and western blot assay were used to detect protein expression in the primary tumor and peritoneal multi-cellular aggregates/spheroids (MCAs/MCSs). OCSCs induced from cell line SKOV3 and HO-8910 were enriched in a serum-free medium (SFM). The effect of EIF5A2 on CSC-like properties was detected by sphere-forming assays, re-differentiation assays, quantitative real-time polymerase chain reaction, western blotting, flow cytometry, cell viability assays, immunofluorescence staining, and in vivo xenograft experiments. RNA-sequencing (RNA-seq) was used to reveal the mechanism by which EIF5A2 positively modulates the stem-like properties of ovarian cancer cells. Results Expression of EIF5A2 was significantly higher in peritoneal MCAs/MCSs compared to matched primary tumors, and EIF5A2 was also unregulated in ovarian cancer cell line-derived spheroids. Knockdown of EIF5A2 reduced the expression of the stem-related markers (ALDH1A1 and OCT-4), inhibited self-renewal ability, improved the sensitivity to chemotherapeutic drugs, and inhibited tumorigenesis in vivo. Mechanistic studies revealed that EIF5A2 knockdown reduced the expression of KLF4, which could partially rescue stem-like properties abolished by EIF5A2 knockdown or strengthened by EIF5A2 overexpression, through the transcription factor E2F1, which directly bind to KLF4 promoter. Conclusion Our results imply that EIF5A2 positively regulates stemness in ovarian cancer cells via E2F1/KLF4 pathway and may serve as a potential target in CSCs-targeted therapy for ovarian cancer.https://doi.org/10.1186/s13287-021-02256-2Ovarian cancerCancer stem cellsChemoresistanceEIF5A2E2F1KLF4
spellingShingle Kun Wang
Yiyang Wang
Yuanjian Wang
Shujie Liu
Chunyan Wang
Shuo Zhang
Tianli Zhang
Xingsheng Yang
EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
Stem Cell Research & Therapy
Ovarian cancer
Cancer stem cells
Chemoresistance
EIF5A2
E2F1
KLF4
title EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
title_full EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
title_fullStr EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
title_full_unstemmed EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
title_short EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
title_sort eif5a2 enhances stemness of epithelial ovarian cancer cells via a e2f1 klf4 axis
topic Ovarian cancer
Cancer stem cells
Chemoresistance
EIF5A2
E2F1
KLF4
url https://doi.org/10.1186/s13287-021-02256-2
work_keys_str_mv AT kunwang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT yiyangwang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT yuanjianwang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT shujieliu eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT chunyanwang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT shuozhang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT tianlizhang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis
AT xingshengyang eif5a2enhancesstemnessofepithelialovariancancercellsviaae2f1klf4axis